Olanzapine causes hypothermia, inactivity, a deranged feeding pattern and weight gain in female Wistar rats.
Olanzapine is an a-typical antipsychotic drug antagonizing predominantly 5-HT and dopamine, but also histamine, muscarin, and α-adrenergic receptors. In humans, Olanzapine induces weight gain and increases the risk of type 2 diabetes. The underlying mechanisms of Olanzapine-induced weight gain are unclear. To study this we administered Olanzapine (5mg/kg) in female Wistar rats on a medium fat diet for 14 days via a permanent gastric catheter twice a day, just prior to the onset and at the middle of dark phase. Food and water intake, locomotor activity and body temperature were measured. Olanzapine acutely induced hypothermia, markedly decreased locomotor activity and increased body weight during 14 days of treatment. Olanzapine treatment did not result in an alteration of 24h food intake, but diurnal patterns of feeding behavior and body temperature were dramatically changed. We conclude that in female Wistar rats Olanzapine has an acute hypothermic effect, that the effect of Olanzapine on feeding behavior is secondary to the effect on activity, and that Olanzapine-induced weight gain is primarily the result of reduction in locomotor activity.
Evers
S S
SS
Department of Neuroendocrinology, University of Groningen, Groningen, The Netherlands. s.s.evers@rug.nl
Calcagnoli
F
F
van Dijk
G
G
Scheurink
A J W
AJ
D000818:Animals; D001569:Benzodiazepines / Q000633:toxicity*; D004334:Drug Administration Schedule; D005247:Feeding Behavior / Q000187:drug effects* / Q000502:physiology / Q000523:psychology*; D005260:Female; D007035:Hypothermia / Q000139:chemically induced* / Q000503:physiopathology; D009043:Motor Activity / Q000187:drug effects* / Q000502:physiology; D000077152:Olanzapine; D051381:Rats; D017208:Rats, Wistar; D013395:Sucrose / Q000008:administration & dosage; D015430:Weight Gain / Q000187:drug effects* / Q000502:physiology
D001569:Benzodiazepines; D013395:Sucrose; D000077152:Olanzapine